Claus Torp Jensen - May 22, 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF INNOVATION OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
May 22, 2023
Transactions value $
-$70,580
Form type
4
Date filed
5/24/2023, 04:06 PM
Previous filing
May 5, 2023
Next filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +9.19K +67.88% 22.7K May 22, 2023 Direct F1
transaction TDOC Common Stock Sale -$70.6K -2.89K -12.71% $24.44 19.8K May 23, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Award $0 +9.19K $0.00 9.19K May 22, 2023 Common Stock 9.19K Direct F3, F4, F5
transaction TDOC Performance Stock Units Options Exercise $0 -9.19K -100% $0.00* 0 May 22, 2023 Common Stock 9.19K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit awards.
F3 Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
F4 Performance award amount determined based on the achievement of certain research and development targets over a two-year performance period.
F5 The performance stock units vested on May 22, 2023.
F6 On May 22, 2023, the reporting person earned 9,191 performance stock units, vesting on May 22, 2023.